GBLX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 21:08):

Stats
Dagens volum	81 311.00
Gjennomsnittsvolum	123 712
Markedsverdi	2.72M
EPS	$0 ( 2024-02-02 )
Neste inntjeningsdato	( $0 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2018-07-11	Poss John C	Buy	3 615	Common Stock
2018-07-11	Poss John C	Buy	11 915	Common Stock
2018-07-11	Poss John C	Buy	20 000	Common Stock
2018-07-11	Poss John C	Buy	1 250	Common Stock
2018-07-11	Poss John C	Buy	30 000	Common Stock

INSIDER POWER
0.00
Last 84 transactions
Buy: 3 790 243 \| Sell: 13 501 701

GB Sciences, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

GB Sciences, Inc. Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Omsetning:	$0
Bruttogevinst:	$-61 660.00 (0.00 %)
EPS:	$-7 356.48

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$0.00520

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0133

Financial Reports:

No articles found.

GB Sciences, Inc.

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.